Predictors of Developing Hepatocellular Carcinoma in Treated HCV-Carriers in Morocco according to University Hospital Experience

Table 1

General features of HCV-treated patients with developed HCC.

Gender
Male	08
Female	12
Mean age	61 years old.
Mean time of HCC occurrence	5 ± 2 years
HCV genotypes
HCV-1	53%
HCV-2	47%
Fibrosis (METAVIR score)
Severe	94.6%
Reduced	5.4%
Response to antiviral treatment
Sustained virological responders	06
Non-SVR patients	14